MARKET INTRODUCTION
Menotropin is a combination of follicle-stimulating hormone and luteinizing hormone. It is also known as human menopausal gonadotropin and most commonly used in the treatment of infertility. Menotropin is extracted from the urine of post-menopausal women and used for the production of FSH and LH hormones to stimulate ovaries to produce eggs. Additionally, it is used in in vitro fertilization and also in stimulating the production of sperm in men.
MARKET DYNAMICS
Rising cases of infertility, working women population and late maternity age are likely to increase the demand of menotropin worldwide. Infertility is becoming prevalent due to wide range of factors such as diabetes, thyroid, smoking, alcohol and drug consumption. For instance, as per the center of disease and prevention (CDC) approximately 12% women face issues in getting pregnant in the U.S. Moreover, in developing countries rising working women population is also stimulating the growth of the market.
MARKET SCOPE
The "Global Menotropin Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of menotropin market with detailed market segmentation by distribution channel, and geography. The global menotropin market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading menotropin market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global menotropin market is segmented on the basis of distribution channel. Based on distribution channel, the market is segmented as hospital pharmacies, retail pharmacies and online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global menotropin market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The menotropin market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting menotropin market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the menotropin market in these regions.
MARKET PLAYERS
The report covers key developments in the menotropin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from menotropin market are anticipated to lucrative growth opportunities in the future with the rising demand for menotropin market in the global market. Below mentioned is the list of few companies engaged in the menotropin market.
The report also includes the profiles of key menotropin market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Merck & Co., Inc
- Ferring B.V.
- BHARAT SERUMS AND VACCINES LIMITED
- Emcure Pharmaceuticals
- Mylan N.V.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS
LIST OF TABLES
LIST OF FIGURES
The List of Companies
1. Merck & Co., Inc
2. Ferring B.V.
3. BHARAT SERUMS AND VACCINES LIMITED
4. Emcure Pharmaceuticals
5. Mylan N.V.